TY - JOUR
T1 - From green technology to functional olive oils
T2 - Assessing the best combination of olive tree-related extracts with complementary bioactivities
AU - Hernáez, Álvaro
AU - Jaramillo, Sara
AU - García-Borrego, Aránzazu
AU - Espejo-Calvo, Juan Antonio
AU - Covas, María Isabel
AU - Blanchart, Gemma
AU - de la Torre, Rafael
AU - Carrasco-Pancorbo, Alegría
AU - Mesa, María Dolores
AU - Fernández-Prior, Maria África
AU - Castañer, Olga
AU - Fitó, Montserrat
N1 - Funding Information:
Acknowledgments: Authors would like to thank Daniel Muñoz-Aguayo and Sònia Gaixas for their technical support, and Stephanie Lonsdale for editing the English text. CIBER de Fisiopatología de la Obesidad y Nutrición is an initiative of the Instituto de Salud Carlos III, Madrid, Spain, and financed by the European Regional Development Fund (ERDF). In addition, we gratefully acknowledge the co-financial support from the companies San Francisco de Asís de Montefrío S. Coop. And., AGROINSUR S.L., AGROISA S.L., Cano Marchal Europa S.L., and Gea Westfalia Separator Iberica S.A, companies participating in the CDTI FEDER INNTERCONECTA “CARDIOL-IVE” consortium project.
Funding Information:
Funding: This research was funded by the Spanish Ministry of Economy, Industry and Competitiveness, through the FEDER INNTERCONECTA Program of the Center for Industrial Technological Development (CDTI) and Junta de Andalucía (grant number ITC-20151142, EXP 00083147, project acronym “CARDIOLIVE”), Instituto de Salud Carlos III (grant numbers CB06/03/0028, CD17/00122, CES12/025, and JR17/00022), and the European Regional Development Fund (ERDF).
Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.
PY - 2021/2
Y1 - 2021/2
N2 - Our aim was to assess the combination of olive tree-related extracts with the most favor-able profile of in vitro bioactive properties. We tested the antioxidant (increment of low-density lipoprotein resistance against oxidation), vasoactive (promotion of nitric oxide release and decrease of endothelin-1 production in human umbilical vein endothelial cells), anti-inflammatory (decrease of the endothelial production of vascular cell adhesion molecule-1), and antithrombotic (reduction of the endothelial release of plasminogen activator inhibitor-1) capacities of six phenolic extracts and three triterpenic acid solutions (Ps and Ts, respectively). We tested extracts alone and in com-bination, at nutritional (Ps: 0.05–0.5 μmol/L; Ts: 0.001–0.1 μmol/L) and nutraceutical doses (Ps: 1–10 μmol/L; Ts: 0.25–10 μmol/L). The combination of Ps rich in 3,4-dihydroxyphenylglycol (76%, P2), hydroxytyrosol (95%, P3), and oleuropein (70%, P4) (final nutritional concentration: 0.15 μmol/L; final nutraceutical concentration: 3 μmol/L) was the best in order to prepare functional products and nutraceuticals with cardioprotective properties, despite the fact that the isolated extract with the greatest in vitro properties was P5 (75% oleocanthal), suggesting a potential synergistic effect among different olive components.
AB - Our aim was to assess the combination of olive tree-related extracts with the most favor-able profile of in vitro bioactive properties. We tested the antioxidant (increment of low-density lipoprotein resistance against oxidation), vasoactive (promotion of nitric oxide release and decrease of endothelin-1 production in human umbilical vein endothelial cells), anti-inflammatory (decrease of the endothelial production of vascular cell adhesion molecule-1), and antithrombotic (reduction of the endothelial release of plasminogen activator inhibitor-1) capacities of six phenolic extracts and three triterpenic acid solutions (Ps and Ts, respectively). We tested extracts alone and in com-bination, at nutritional (Ps: 0.05–0.5 μmol/L; Ts: 0.001–0.1 μmol/L) and nutraceutical doses (Ps: 1–10 μmol/L; Ts: 0.25–10 μmol/L). The combination of Ps rich in 3,4-dihydroxyphenylglycol (76%, P2), hydroxytyrosol (95%, P3), and oleuropein (70%, P4) (final nutritional concentration: 0.15 μmol/L; final nutraceutical concentration: 3 μmol/L) was the best in order to prepare functional products and nutraceuticals with cardioprotective properties, despite the fact that the isolated extract with the greatest in vitro properties was P5 (75% oleocanthal), suggesting a potential synergistic effect among different olive components.
KW - 3,4-dihy-droxyphenylglycol
KW - Bioactivity
KW - Functional olive oil
KW - Hydroxytyrosol
KW - Oleocanthal
KW - Oleuropein
KW - Olive tree
KW - Phenolic compound
KW - Triterpenes
UR - http://www.scopus.com/inward/record.url?scp=85100043850&partnerID=8YFLogxK
U2 - 10.3390/antiox10020202
DO - 10.3390/antiox10020202
M3 - Article
AN - SCOPUS:85100043850
SN - 2076-3921
VL - 10
SP - 1
EP - 14
JO - Antioxidants
JF - Antioxidants
IS - 2
M1 - 202
ER -